IONETIX Produces First Batch of Actinium-225 News IONETIX Produces First Batch of Actinium-225global_0m58uj2024-06-07T12:18:39+00:00June 7, 2024|
Ionetix Produces First Alpha-Emitting Radionuclide at New Isotope Production Facility News Ionetix Produces First Alpha-Emitting Radionuclide at New Isotope Production Facilityglobal_0m58uj2023-04-18T00:58:39+00:00April 18, 2023|
Convergent Therapeutics and IONETIX Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225) News Convergent Therapeutics and IONETIX Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)global_0m58uj2022-05-25T15:14:16+00:00May 25, 2022|
IONETIX AND ATONCO SIGN A PARTNERSHIP AGREEMENT TO FIGHT BLADDER CANCER News IONETIX AND ATONCO SIGN A PARTNERSHIP AGREEMENT TO FIGHT BLADDER CANCERglobal_0m58uj2022-05-15T02:35:05+00:00May 18, 2022|
February is American Heart Month News February is American Heart Monthglobal_0m58uj2022-02-01T01:50:05+00:00February 1, 2022|
IONETIX and PRECISION MOLECULAR Inc. Announce Supply Agreement for Astatine-211 News IONETIX and PRECISION MOLECULAR Inc. Announce Supply Agreement for Astatine-211global_0m58uj2022-01-26T15:25:07+00:00January 26, 2022|
IONETIX and POINT Biopharma Announce Ac-225 Supply Agreement News IONETIX and POINT Biopharma Announce Ac-225 Supply Agreementglobal_0m58uj2021-11-10T19:50:48+00:00November 10, 2021|
IONETIX Announces Targeted Alpha Therapy Manufacturing Center News IONETIX Announces Targeted Alpha Therapy Manufacturing Centerjsctek_ag5wy82021-10-07T23:07:45+00:00October 7, 2021|
Cardiac PET: The safest option during COVID-19 News Cardiac PET: The safest option during COVID-19jsctek_ag5wy82021-10-07T21:48:42+00:00March 7, 2021|
